A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Testolactone
Magnesium glycinate
The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Sodium fluorophosphate
The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Glycerin
The therapeutic efficacy of Glycerin can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Dipotassium phosphate
The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Monopotassium phosphate
The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Sorbitol
The therapeutic efficacy of Sorbitol can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Magnesium cation
The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Magnesium oxide
The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Sodium bicarbonate.
Testolactone
Propacetamol
Sodium bicarbonate can cause a decrease in the absorption of Propacetamol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferric maltol
Sodium bicarbonate can cause a decrease in the absorption of Ferric maltol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferric pyrophosphate
Sodium bicarbonate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Iron
Sodium bicarbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferric oxyhydroxide
Sodium bicarbonate can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Tetraferric tricitrate decahydrate
Sodium bicarbonate can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferrous fumarate
Sodium bicarbonate can cause a decrease in the absorption of Ferrous fumarate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferrous succinate
Sodium bicarbonate can cause a decrease in the absorption of Ferrous succinate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferrous gluconate
Sodium bicarbonate can cause a decrease in the absorption of Ferrous gluconate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferric cation
Sodium bicarbonate can cause a decrease in the absorption of Ferric cation resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Ferric hydroxide
Sodium bicarbonate can cause a decrease in the absorption of Ferric hydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testolactone
Sodium feredetate
Sodium bicarbonate can cause a decrease in the absorption of Sodium feredetate resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3